Oral vaccination and vaccine-entrapped microparticle delivery system

Yaoxue Xuebao

Volumn 42, Issue 3, 2007, Pages 245-251

  Li, Feng Qian ^a   Fei, Yi Bo ^a   Su, Hua ^a   Hu, Jin Hong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Lectin; Microparticle; Mucosal immunity; Nanoparticle; Oral vaccine delivery; Peyer's patch

Indexed keywords

MICROSPHERE; NANOPARTICLE; VACCINE;

ANIMAL; ARTICLE; DRUG DELIVERY SYSTEM; HUMAN; IMMUNOLOGY; INTESTINE ABSORPTION; METHODOLOGY; MUCOSAL IMMUNITY; ORAL DRUG ADMINISTRATION; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNITY, MUCOSAL; INTESTINAL ABSORPTION; MICROSPHERES; NANOPARTICLES; VACCINATION; VACCINES;

EID: 34247584225     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Smith PL, Wall DA, Gochoco C, et al. Oral absorption of peptides and proteins [J]. Adv Drug Deliv Rev, 1992,8:253-290.
2. Wang XQ, Huang J, Dai JD, et al. Long-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloid [J]. Int J Pharm, 2006,322:146-153.
3. Chen H, Langer R. Oral particulate delivery: status and future trends [J]. Adv Drug Deliv Rev, 1998,34:339-350.
4. Simecka JW. Mucosal immunity of the gastrointestinal tract and oral tolerance [J]. Adv Drug Deliv Rev, 1998, 34:235-259.
5. Owen RI, Jones AL. Epithelial specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles [J]. Gastroenterology, 1974,66:189-203.
6. John HE, Charlotte J. Hammond JA, et al. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches [J]. J Control Release, 1990,11:205-214.
7. Russell-Jones GJ. Oral vaccine delivery [J]. J Control Release, 2000,65:49-54.
8. Yeh PY, Ellens H, Smith PL. Physiological considerations in the design of participate dosage forms for oral vaccine delivery [J]. Adv Drug Deliv Rev, 1998,34:123-133.
9. van der Lubben IM, Verhoef JC, Borchard G, et al. Chitosan for mucosal vaccination [J]. Adv Drug Deliv Rev, 2001,52:139-144.
10. van der Lubben IM, van Opdorp FA, Hengeveld MR, et al. Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model [J]. J Drug Target, 2002,10:449-456.
11. Smith MW, Thomas NW, Jenkins NW, et al. Selective transport of microparticles across Peyer's patches follicle associated M-cells from mice and rats [J]. Exp Phys, 1995,80:735-743.
12. Jani PU, McCarthy DE, Florence AT. Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake after a single oral dose [J]. Int J Pharm, 1992,86:239-246.
13. Eldridge JH, Stass JK, Meulbroek JA, et al. Biodegradable microspheres as a vaccine system [J]. Mol Immunol, 1991,28:287-295.
14. O'Hagan DT. Microparticles and polymers for the mucosal delivery of vaccines [J]. Adv Drug Deliv Rev, 1998,34:305-320.
15. van der Lubben IM, Verhoef JC, van Aelst AC, et al. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches [J]. Biomaterials, 2001,22:687-694.
16. Jung T, Kamm W, Breitenbach A, et al. Tetanus toxoid loaded nanoparticles from sulfobutylated poly (vinyl alcohol)-graft-poly (lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice [J]. Pharm Res, 2001,18:352-360.
17. Al-Kassas RS, Rezk NJ. Enterotoxigenic E. Coli colonization factor antigen (CFA/II)-loaded polyisobutyl-cyanoacrylate nanoparticles for oral immunization [J]. STP Pharm Sci, 2003,13:93-98.
18. Behrens I, Pena AI, Alonso MJ, et al. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport [J]. Pharm Res. 2002,19:1185-1193.
19. Sun CJ, Pan SP, Xie QX, et al. Preparation of chitosan-plasmid DNA nanoparticles encoding zona pellucida glycoprotein-3alpha and its expression in mouse [J]. Mol Reprod Dev. 2004,68:182-188.
20. Chew JL, Wolfowicz CB, Mao HQ, et al. Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice [J]. Vaccine, 2003,21:2720-2729.
21. Li FQ, Lu B. Overview of researches about the microparticular drug delivery system absorbed through gastrointestinal tract [J]. World Pharm, 2000,21:307-310.
22. Brayden DJ, Baird AW. Apical membrane receptors on intestinal M cells: potential targets for vaccine delivery [J]. Adv Drug Deliv Rev, 2004,56:721-726.
23. Clark MA, Jepson MA, Simmons NL, et al. Differential expression of lectin-binding sites defines mouse intestinal M cell [J]. J Histochem Cytochem, 1993,41:1679-1687.
24. Zhang N, Ping Q, Huang G, et al. Lectin-modified solid lipid, nanoparticles as carriers for oral administration of insulin [J]. Int J Pharm, 2006,327:153-159.
25. Lehr CM. Lectin-mediated drug delivery: the second generation of bioadhesives [J]. J Control Release, 2000, 65:19-29.
26. Chen J, Gao JY, Chang X, et al. Employing the ultrathin cryosectioning and immunolabeling technique to study intestinal microfole cells [J]. Shanghai J Immunol, 2003,23:10-12.
27. Ezpeleta I, Arangoa MA, Irache JM, et al. Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal mucus [J]. Int J Pharm, 1999,191:25-32.
28. Chong CSW, Cao M, Wong WW, et al. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery [J]. J Control Release, 2005,102:85-99.
29. Mishra D, Dubey V, Asthana A, et al. Elastic liposomes mediated transcutaneous immunization against Hepatitis B [J]. Vaccine, 2006,24:4847-4855.
30. Gupta PN, Mahor S, Rawat A, et al. Lectin anchored stabilized biodegradable nanoparticles for oral immunization: 1. Development and in vitro evaluation [J]. Int J Pharm, 2006,318:163-173.
31. Artursson P, Lindmark T, Davis SS, et al. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2) [J]. Pharm Res, 1994,11:1358-1361.
32. Calvo P, Remunan-Lopez C, Vila-Jato JL, et al. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers [J]. J Appl Polym Sci, 1997,16:125-132.
33. Chen H, Torchilin V, Langer R. Lectin-bearing polymerized liposomes as potential oral vaccine carriers [J]. Pharm Res. 1996,13:1378-1383.
34. Lambkin I, Pinilla C. Hamashin C, et al. Toward targeted oral vaccine delivery systems: selection of lectin mimetics from combinatorial libraries [J]. Pharm Res, 2003,20:1258-1266.
35. Neutra MR, Frey A, Kraehenbuhl JP. Epithelial M cells: gateways for mucosal infection and immunization [J]. Cell, 1996,86:345-348.
36. Foster N, Hirst BH. Exploiting receptor biology for oral vaccination with biodegradable particulates [J]. Adv Drug Deliv Rev, 2005,57:431-450.